1. Home
  2. VSTM vs ULBI Comparison

VSTM vs ULBI Comparison

Compare VSTM & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • ULBI
  • Stock Information
  • Founded
  • VSTM 2010
  • ULBI 1990
  • Country
  • VSTM United States
  • ULBI United States
  • Employees
  • VSTM N/A
  • ULBI N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • ULBI Industrial Machinery/Components
  • Sector
  • VSTM Health Care
  • ULBI Miscellaneous
  • Exchange
  • VSTM Nasdaq
  • ULBI Nasdaq
  • Market Cap
  • VSTM 132.0M
  • ULBI 158.1M
  • IPO Year
  • VSTM 2012
  • ULBI 1992
  • Fundamental
  • Price
  • VSTM $4.00
  • ULBI $7.63
  • Analyst Decision
  • VSTM Strong Buy
  • ULBI Strong Buy
  • Analyst Count
  • VSTM 8
  • ULBI 1
  • Target Price
  • VSTM $14.57
  • ULBI $14.00
  • AVG Volume (30 Days)
  • VSTM 985.6K
  • ULBI 74.2K
  • Earning Date
  • VSTM 11-06-2024
  • ULBI 11-08-2024
  • Dividend Yield
  • VSTM N/A
  • ULBI N/A
  • EPS Growth
  • VSTM N/A
  • ULBI 115.20
  • EPS
  • VSTM N/A
  • ULBI 0.54
  • Revenue
  • VSTM $10,000,000.00
  • ULBI $165,152,000.00
  • Revenue This Year
  • VSTM N/A
  • ULBI $10.59
  • Revenue Next Year
  • VSTM $108.05
  • ULBI $8.72
  • P/E Ratio
  • VSTM N/A
  • ULBI $14.17
  • Revenue Growth
  • VSTM N/A
  • ULBI 9.95
  • 52 Week Low
  • VSTM $2.10
  • ULBI $6.36
  • 52 Week High
  • VSTM $14.22
  • ULBI $13.39
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 56.35
  • ULBI 40.25
  • Support Level
  • VSTM $3.72
  • ULBI $7.10
  • Resistance Level
  • VSTM $4.15
  • ULBI $8.17
  • Average True Range (ATR)
  • VSTM 0.37
  • ULBI 0.39
  • MACD
  • VSTM -0.04
  • ULBI -0.06
  • Stochastic Oscillator
  • VSTM 39.39
  • ULBI 21.12

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

Share on Social Networks: